本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

CervoMed

7.05
-0.0600-0.84%
盤後7.050.00000.00%16:43 EDT
成交量:6.00萬
成交額:43.41萬
市值:6,523.17萬
市盈率:-2.73
高:7.46
開:7.14
低:7.01
收:7.11
52周最高:16.94
52周最低:1.80
股本:925.27萬
流通股本:493.43萬
量比:1.26
換手率:1.22%
股息:- -
股息率:- -
每股收益(TTM):-2.5788
每股收益(LYR):-2.0179
淨資產收益率:-54.21%
總資產收益率:-33.63%
市淨率:1.95
市盈率(LYR):-3.49

資料載入中...

公司資料

公司名字:
CervoMed
交易所:
NASDAQ
成立時間:
2010
員工人數:
15
公司地址:
20 Park Plaza,Suite 424,Boston,Massachusetts,United States
郵編:
02116
電話:
傳真:
- -
簡介:
CervoMed Inc.於2015年6月18日在特拉華州註冊成立。該公司是一家臨床階段的生物技術公司,專註於開發與年齡相關的神經系統疾病的治療方法。

董事

名稱
職位
John Alam
Director, President and Chief Executive Officer
Robert J. Cobuzzi, Jr.
Director, Chief Operating Officer
David Quigley
Director
Frank Zavrl
Director
Jane H. Hollingsworth
Director
Jeff Poulton
Director
Joshua S. Boger
Director
Marwan Sabbagh
Director
Sylvie Gregoire
Director

股東

名稱
職位
John Alam
Director, President and Chief Executive Officer
Robert J. Cobuzzi, Jr.
Director, Chief Operating Officer
William R. Elder
Chief Financial Officer, General Counsel and Corporate Secretary
Kelly Blackburn
Executive Vice President, Clinical Development
Mark De Rosch
Executive Vice President, Regulatory and Government Affairs and Program Management